Total Payments
$16,303
2024 Payments
$2,610
Companies
69
Transactions
1,013
Medicare Patients
2,724
Medicare Billing
$258,716
Payment Breakdown by Category
Food & Beverage$15,412 (94.5%)
Education$890.80 (5.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,412 | 995 | 94.5% |
| Education | $890.80 | 18 | 5.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,369 | 120 | $0 (2024) |
| Celgene Corporation | $1,224 | 71 | $0 (2024) |
| Genentech USA, Inc. | $1,207 | 101 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,038 | 58 | $0 (2024) |
| Amgen Inc. | $981.23 | 51 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $876.33 | 53 | $0 (2024) |
| Merck Sharp & Dohme LLC | $816.85 | 64 | $0 (2024) |
| Janssen Biotech, Inc. | $795.73 | 38 | $0 (2024) |
| PFIZER INC. | $680.04 | 54 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $530.35 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,610 | 122 | Celgene Corporation ($379.28) |
| 2023 | $2,095 | 109 | Celgene Corporation ($219.01) |
| 2022 | $1,868 | 101 | E.R. Squibb & Sons, L.L.C. ($174.94) |
| 2021 | $1,060 | 57 | AstraZeneca Pharmaceuticals LP ($184.59) |
| 2020 | $1,096 | 68 | Merck Sharp & Dohme Corporation ($135.60) |
| 2019 | $2,516 | 184 | Genentech USA, Inc. ($275.72) |
| 2018 | $2,896 | 202 | Amgen Inc. ($398.59) |
| 2017 | $2,161 | 170 | Genentech USA, Inc. ($392.72) |
All Payment Transactions
1,013 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $16.98 | General |
| Category: Hematology/Oncology | ||||||
| 12/18/2024 | PFIZER INC. | ELREXFIO (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $31.01 | General |
| Category: Oncology | ||||||
| 12/11/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TALVEY (Biological) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $24.80 | General |
| Category: Hematology | ||||||
| 11/19/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $16.39 | General |
| Category: Hematology/Oncology | ||||||
| 11/14/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Oncology | ||||||
| 11/12/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: DESMOID TUMORS | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug), TGCT | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/30/2024 | PFIZER INC. | BRAFTOVI (Drug), MEKTOVI | Education | In-kind items and services | $13.04 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $16.86 | General |
| Category: Hematology | ||||||
| 10/25/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.57 | General |
| 10/16/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $25.15 | General |
| Category: Hematology | ||||||
| 10/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Oncology | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Oncology | ||||||
| 10/09/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,023 | 5,031 | $298,640 | $86,943 |
| 2022 | 22 | 898 | 7,114 | $276,259 | $75,287 |
| 2021 | 5 | 335 | 464 | $113,603 | $38,573 |
| 2020 | 5 | 468 | 755 | $190,365 | $57,913 |
Total Patients
2,724
Total Services
13,364
Medicare Billing
$258,716
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 113 | 245 | $85,015 | $27,449 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 159 | 322 | $82,432 | $25,274 | 30.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 124 | 124 | $61,504 | $16,766 | 27.3% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 25 | 30 | $20,100 | $4,817 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 62 | $10,726 | $3,245 | 30.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 107 | 171 | $1,710 | $1,428 | 83.5% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 20 | 26 | $13,624 | $1,253 | 9.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $4,386 | $1,172 | 26.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 55 | 89 | $3,204 | $921.15 | 28.8% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 44 | 61 | $2,806 | $814.96 | 29.0% |
| 77075 | Complete x-ray of body bones | Office | 2023 | 15 | 15 | $2,250 | $784.35 | 34.9% |
| 83550 | Iron binding capacity | Office | 2023 | 41 | 58 | $1,740 | $497.06 | 28.6% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 31 | 3,550 | $1,775 | $408.25 | 23.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 23 | 27 | $1,377 | $399.06 | 29.0% |
| 82746 | Folic acid level, serum | Office | 2023 | 24 | 27 | $1,350 | $389.07 | 28.8% |
| 83540 | Iron level | Office | 2023 | 41 | 58 | $1,276 | $367.72 | 28.8% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 17 | 18 | $972.00 | $280.80 | 28.9% |
| 85044 | Red blood count, manual test | Office | 2023 | 58 | 65 | $975.00 | $274.30 | 28.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 27 | 30 | $810.00 | $228.30 | 28.2% |
| 86431 | Rheumatoid factor level | Office | 2023 | 17 | 17 | $323.00 | $89.63 | 27.7% |
| 84550 | Uric acid level, blood | Office | 2023 | 15 | 19 | $285.00 | $84.17 | 29.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 64 | 193 | $66,971 | $21,670 | 32.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 115 | 115 | $57,040 | $15,516 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 91 | 202 | $51,712 | $15,225 | 29.4% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2022 | 45 | 49 | $32,830 | $8,367 | 25.5% |
About Dr. Antony Charles, MD
Dr. Antony Charles, MD is a Hematology & Oncology healthcare provider based in Gainesville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1467435222.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Antony Charles, MD has received a total of $16,303 in payments from pharmaceutical and medical device companies, with $2,610 received in 2024. These payments were reported across 1,013 transactions from 69 companies. The most common payment nature is "Food and Beverage" ($15,412).
As a Medicare-enrolled provider, Charles has provided services to 2,724 Medicare beneficiaries, totaling 13,364 services with total Medicare billing of $258,716. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology, Hematology & Oncology
- Location Gainesville, GA
- Active Since 11/25/2005
- Last Updated 08/04/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1467435222
Products in Payments
- OPDIVO (Biological) $958.42
- KEYTRUDA (Biological) $741.65
- REBLOZYL (Biological) $587.77
- IMBRUVICA (Drug) $517.13
- Avastin (Biological) $426.97
- Lenvima (Drug) $361.39
- KISQALI (Drug) $344.70
- JAKAFI (Drug) $322.88
- ADCETRIS (Biological) $322.81
- TECENTRIQ (Biological) $315.52
- DARZALEX (Biological) $257.66
- TAGRISSO (Drug) $253.22
- NINLARO (Drug) $227.35
- VENCLEXTA (Drug) $220.62
- LIBTAYO (Biological) $216.24
- ZEPZELCA (Drug) $211.19
- LYNPARZA (Drug) $201.78
- Pomalyst (Drug) $201.17
- IBRANCE (Drug) $197.60
- Stivarga (Drug) $194.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Gainesville
Dr. Thomas George, Md, MD
Hematology & Oncology — Payments: $32,442
Hematology & Oncology $32,442
Thomas Marsland, Md, MD
Hematology & Oncology — Payments: $22,438
Hematology & Oncology $22,438
Dr. Marc Zumberg, Md, MD
Hematology & Oncology — Payments: $20,658
Hematology & Oncology $20,658
Nam Dang, Md, MD
Hematology & Oncology — Payments: $20,524
Hematology & Oncology $20,524
Sridharan Gururangan, Md, MD
Hematology & Oncology — Payments: $20,516
Hematology & Oncology $20,516
Saloni Tanna, M.d, M.D
Hematology & Oncology — Payments: $17,094
Hematology & Oncology $17,094